Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis

References

• Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–45.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–61.
   PubMed Web of Science ®Google Scholar
• Hunder GG. Epidemiology of giant-cell arteritis. Cleve Clin J Med 2002;69(Suppl 2):SII-79–82.
   Google Scholar
• Nir-Paz R, Gross A, Chajek-Shaul T. Sex differences in giant cell arteritis. J Rheumatol. 2002;29:1219–23.
   PubMed Web of Science ®Google Scholar
• Ray JG, Mamdani MM, Geerts WH. Giant cell arteritis and cardiovascular disease in older adults. Heart. 2005;91:324–8.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Piñeiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004;83:342–7.
   PubMed Web of Science ®Google Scholar
• Matthews JL, Gilbert DN, Farris BK, Siatkowski RM. Prevalence of diabetes mellitus in biopsy-positive giant cell arteritis. J Neuroophthalmol. 2012;32:202–6.
   PubMed Web of Science ®Google Scholar
• Larsson K, Mellström D, Nordborg E, Odén A, Nordborg E. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis. 2006;65:529–32.
   PubMed Web of Science ®Google Scholar
• Pfadenhauer K, Esser M, Berger K. Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica – an ultrasonographic case-control study. J Rheumatol. 2005;32:2356–60.
   PubMed Web of Science ®Google Scholar
• Le Page L, Duhaut P, Seydoux D, Bosshard S, Ecochard R, Abbas F, et al. Incidence of cardiovascular events in giant cell arteritis: preliminary results of a prospective double cohort study (GRACG). Rev Med Intern. 2006;27:98–105.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Lopez-Diaz MJ, Martin J, Llorca J, Gonzalez-Gay MA. Atherosclerosis in patients with biopsy-proven giant cell arteritis. Arthritis Rheum. 2007;57:1481–6.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Kermani TA, Muratore F, Crowson CS, Matteson EL, Warrington KJ. Statin use in giant cell arteritis: a retrospective study. J Rheumatol. 2013;40:910–15.
   PubMed Web of Science ®Google Scholar
• Hafner F, Haas E, Belaj K, Froehlich H, Gary T, Eller P, et al. Endothelial function and carotid intima media thickness in giant-cell arteritis. Eur J Clin Invest. 2014;44:249–56.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
   PubMed Web of Science ®Google Scholar
• Robson JC, Kiran A, Maskell J, Hutchings A, Arden N, Dasgupta B, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rhuem Dis. 2015;74:129–35.
   Google Scholar
• Tomasson G, Peloquin C, Mohammad A, Love TJ, Zhang Y, Choi HK, et al. Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis. A cohort study. Ann Intern Med. 2014;160:73–80.
   PubMed Web of Science ®Google Scholar
• Durand M, Thomas SL. Incidence of infections in patients with giant cell arteritis: a cohort study. Arthritis Care Res (Hoboken). 2012;64:581–8.
   PubMed Web of Science ®Google Scholar
• Machado EB, Gabriel SE, Beard CM, Michet CJ, O'Fallon WM, Ballard DJ. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease. Int J Epidemiol. 1989;18:836–41.
   PubMed Web of Science ®Google Scholar
• Udayakumar PD, Chandran AK, Crowson CS, Warrington KJ, Matteson EL. Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population based retrospective cohort study. Arthritis Care Res (Hoboken). 2015;67:396–402.
   PubMed Web of Science ®Google Scholar
• Duhaut P, Pinède L, Demolombe-Ragué S, Dumontet C, Ninet J, Seydoux D, et al Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum. 1998;41:1960–5.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev. 2004;3:46–53.
   PubMed Web of Science ®Google Scholar
• Weyand CM, Goronzy JJ. Giant cell arteritis and polymyalgia rheumatica. New Engl J Med. 2014;371:50–7.
   PubMed Web of Science ®Google Scholar
• Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation. 2008;118:1276–84.
   PubMed Web of Science ®Google Scholar
• Ly KH, Régent A, Tamby MC, Mouthon L. Pathogenesis of giant cell arteritis: more than just an inflammatory condition? Autoimmun Rev. 2010;9:635–45.
   PubMed Web of Science ®Google Scholar
• Casey J, Sturm Jr C. Impaired response of lymphocytes from non-insulin dependent diabetics to staphage lysate and tetanus antigen. J Clin Microbiol. 1982;15:109–14.
   PubMed Web of Science ®Google Scholar
• Casey JI, Heeter BJ, Klyschevich KA. Impaired response of lymphocytes from diabetic subjects to antigen of Staphylococcus aureus. J Infect Dis. 1977;136:495–501.
   PubMed Web of Science ®Google Scholar
• MacCuish AC, Urbaniak SJ, Campbell CJ, Duncan LJ, Irvine WJ. Phytohemagglutinin transformation and circulating lymphocyte subpopulations in insulin-dependent diabetic patients. Diabetes. 1974;23:708–12.
   PubMed Web of Science ®Google Scholar
• Speert DP, Silva Jr J. Abnormalities of in vitro lymphocyte response to mitogens in diabetic children during acute ketoacidosis. Am J Dis Child. 1978;132:1014–17.
   PubMedGoogle Scholar
• Ungprasert P, Koster MJ, Warrington KJ. Coronary artery disease in giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44:581–91.
   Google Scholar
• Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52:722–32.
   PubMed Web of Science ®Google Scholar
• Bessant R, Hingorani, Patel L, MacGregor A, Isenberg DA, Rahman A. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford). 2004;43:924–9.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Charoenpong P, Ratanasrimetha P, Thongprayoon C, Cheungpasitporn W, Suksaranjit P. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol. 2014:33:1099–104.
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Suksaranjit P, Spanuchart I, Leeaphorn N, Permpalung N. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2014;44:63–7.
   PubMed Web of Science ®Google Scholar